Selective changes in white matter integrity in MCI and older adults with cognitive complaints

Yang Wang1, John D West, Laura A Flashman

  • 1Center for Neuroimaging, Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN, USA.

Abstract

Insights

Diffusion tensor imaging reveals early white matter changes in the parahippocampal region, even before mild cognitive impairment develops. These findings suggest potential for earlier Alzheimer's disease detection using diffusion tensor imaging.

Area of Science:

  • Neuroimaging
  • Neuroscience
  • Radiology

Background:

  • White matter alterations are known in Alzheimer's disease (AD) and mild cognitive impairment (MCI).
  • Earlier pre-clinical or prodromal stages of neurodegeneration remain understudied using diffusion tensor imaging (DTI).

Purpose of the Study:

  • To investigate white matter changes using DTI in individuals with subjective cognitive complaints but no objective impairment.
  • To compare DTI metrics in individuals with cognitive complaints, MCI, and healthy controls.

Main Methods:

  • Cross-sectional study comparing healthy controls (n=35), cognitive complaint group (n=29), and MCI group (n=28).
  • Whole-brain DTI and structural MRI were acquired.
  • Tract-Based Spatial Statistics (TBSS) analyzed fractional anisotropy and diffusivities in white matter tracts.

Main Results:

  • Mild cognitive impairment (MCI) group showed reduced fractional anisotropy and increased radial diffusivity in bilateral parahippocampal white matter compared to controls.
  • The cognitive complaint group exhibited intermediate DTI values between MCI and control groups.
  • Parahippocampal white matter DTI indices correlated with memory performance, independent of hippocampal atrophy.

Conclusions:

  • DTI detects parahippocampal white matter abnormalities in MCI and suggests subtle changes in earlier cognitive complaint stages.
  • These findings support DTI's potential for early detection of neurodegenerative processes in prodromal AD.
  • This research contributes to understanding brain aging and neurodegenerative diseases through advanced imaging techniques.

Related Concept Videos

Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...